➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Dow
Boehringer Ingelheim
Medtronic
Moodys

Last Updated: January 20, 2021

DrugPatentWatch Database Preview

Litigation Details for SUCAMPO AG v. TEVA PHARMACEUTICAL INDUSTRIES LTD. (D.N.J. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

SUCAMPO AG v. TEVA PHARMACEUTICAL INDUSTRIES LTD. (D.N.J. 2017)

Docket   Start Trial Date Filed 2017-09-25
Court District Court, D. New Jersey Date Terminated 2018-09-19
Cause 15:1126 Patent Infringement Assigned To Peter G. Sheridan
Jury Demand None Referred To Lois H. Goodman
Parties SUCAMPO PHARMACEUTICALS, INC.
Patents 6,414,016; 6,583,174; 6,982,283; 7,064,148; 7,795,312; 8,026,393; 8,071,613; 8,097,653; 8,114,890; 8,338,639; 8,389,542; 8,748,481
Attorneys WILLIAM C. BATON
Firms Patterson Belknap Webb & Tyler LLP
Link to Docket External link to docket
Small Molecule Drugs cited in SUCAMPO AG v. TEVA PHARMACEUTICAL INDUSTRIES LTD.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for SUCAMPO AG v. TEVA PHARMACEUTICAL INDUSTRIES LTD. (D.N.J. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 Sucampo AG owns United States Patent No. 6,414,016 (“the ’016 patent”) titled “Anti-Constipation Composition…action for infringement of United States Patent Nos. 6,414,016, 8,071,613, 7,795,312, 6,982,283, 8,097,6536,414,016 B1 Ueno (… US 6,414,016 B1 1 … US 6,414,016 B1 External link to document
0000-00-00 31 United States Patent Nos. 6,414,016 (“the ‘016 Patent”), 8,071,613 (“the ‘613 Patent”), 7,795,312 (… (“the ‘312 Patent”), 8,748,481 (“the ‘481 Patent”), 6,982,283 (“the ‘283 Patent”), 8,026,393 (“the…the ‘393 Patent”), 8,097,653 (“the ‘653 Patent”), 8,338,639 (“the ‘639 Patent”), and 8,389,542 (“the …the ‘542 Patent”) (collectively, the “Sucampo Patents”). Plaintiffs’ commencement of the Patent Litigation… This action for patent infringement (the “Patent Litigation”) has been brought by External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Baxter
Boehringer Ingelheim
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.